Analyst consensus rating
Mesoblast Analyst Rating: none
Direct answer
Mesoblast's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.00.
Forecast evidence checked November 1, 2026.
Get free Mesoblast email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.16
- Average price target
- $37.00
- High price target
- $39.00
- Low price target
- $35.00
- Low target gap
- +130.9%
- Target upside
- +144.1%
- High target gap
- +157.3%
- Target range width
- 26.4%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- November 1, 2026
- Valid through
- November 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Mesoblast?
Mesoblast has a verified none consensus. The same dataset has an average price target of $37.00.
How far are Mesoblast's low and high targets from the recorded price?
The low target implies +130.9%, while the high target implies +157.3%.
How many analysts are included in Mesoblast's consensus?
The verified consensus includes 2 analysts.
How is Mesoblast's target upside or downside calculated?
The average target of $37.00 is divided by the recorded price of $15.16, then one is subtracted to produce +144.1%. This does not guarantee a future return.
When was Mesoblast's analyst forecast verified?
The data was verified on 2026-11-01. The dataset is valid through 2026-11-08.